Skip to main content
Back
Watch Compare

Opus Genetics, Inc.

Data quality: 100%
IRD
NASDAQ Manufacturing Chemicals
$5.36
▼ $0.14 (-2.55%)
Mkt Cap: 389.69 M
Price
$5.46
Mkt Cap
389.69 M
Day Range
—
52-Week Range
—
Volume
—
Open —
50D / 200D Avg
—
50D / 200D Avg
—

Quick Summary

Key Takeaways

Revenue grew 121.57% annually over 5 years — strong growth
Debt/Equity of 0.18 — conservative balance sheet
Negative free cash flow of -35.25 M
Revenue growth is decelerating — 1Y growth trails 5Y average by 92.42%

Growth

Revenue Growth (5Y)
121.57%
Above sector avg (1.82%)
Revenue (1Y)29.15%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Quality

Return on Equity
-423.13%
Below sector avg (-54.01%)
ROIC-239.09%
Net Margin-349.33%
Op. Margin-271.90%

Safety

Debt / Equity
0.18
Below sector avg (0.30)
Current Ratio1.23
Interest Coverage-299.22

Valuation

PE (TTM|NTM)
-7.86 | -9.43
Below sector avg (-1.49)
P/B Ratio65.31
EV/EBITDAN/A
Dividend YieldN/A

Price History

Financial Trends

Peer Comparison

vs Manufacturing sector median (1385 peers)
Metric Stock Sector Median
P/E -7.9 -1.5
P/B 65.3 1.6
ROE % -423.1 -54.0
Net Margin % -349.3 -41.5
Rev Growth 5Y % 121.6 1.8
D/E 0.2 0.3

Analyst Price Target

14 analysts
Buy
Current
$5.36
+85.2%
Target
$9.93
$8.00
$9.50
$15.00
Forecast
Forward P/E -9.43
Forward EPS -$0.57
Est. Revenue 17.26 M

Earnings Estimates

Period EPS Est. Revenue Est. Analysts
FY2027 -$0.57
-$0.74 – -$0.28
 17.26 M 7
FY2026 -$0.57
-$0.72 – -$0.35
 16.18 M 7

Earnings Surprises

Last 4 quarters
Quarter Est. EPS Actual EPS Surprise
Q42025 -$0.10 -$0.21 -110.0%
Q32025 -$0.13 -$0.25 -92.3%
Q22025 -$0.26 -$0.12 +53.9%
Q12025 -$0.21 -$0.24 -17.1%

ETFs Holding This Stock

BOSVX BOSVX
0.00% weight
BSVO logo BSVO EA Bridgeway Omni Small-Cap Value ETF
0.00% weight

All Fundamental Metrics
Growth
Revenue Growth (1Y) 29.15% Revenue Growth (3Y) -13.67%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) 121.57% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 14.20 M Net Income (TTM) -49.59 M
ROE -423.13% ROA -132.62%
Gross Margin N/A Operating Margin -271.90%
Net Margin -349.33% Free Cash Flow (TTM) -35.25 M
ROIC -239.09% FCF Growth (3Y) N/A
Safety
Debt / Equity 0.18 Current Ratio 1.23
Interest Coverage -299.22 Asset Turnover 0.38
Working Capital 6.82 M Tangible Book Value 5.97 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -7.86 Forward P/E -9.43
P/B Ratio 65.31 P/S Ratio 27.45
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S 22.58 Fwd Earnings Yield N/A
FCF Yield -9.05%
Market Cap 389.69 M Enterprise Value 359.94 M
Per Share
EPS (Diluted TTM) -0.80 Revenue / Share 0.20
FCF / Share -0.49 OCF / Share -0.49
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 71.09%
SBC-Adj. FCF -38.65 M Growth Momentum -92.42

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 14.20 M 10.99 M 19.05 M 39.85 M 589,000.0
Net Income -49.59 M -57.53 M -9.99 M 17.89 M -56.69 M
EPS (Diluted) -0.80 -2.15 -0.46 0.87 -3.82
Gross Profit — — — — —
Operating Income -38.60 M -62.07 M -10.56 M 18.23 M -22.71 M
EBITDA — — — — —
R&D Expenses — — — — —
SG&A Expenses — — — — —
D&A — — — — —
Interest Expense 129,000.0 — 0.0 9,000.0 2,000.0
Income Tax 0.0 0.0 12,000.0 315,000.0 0.0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 50.24 M 36.86 M 53.95 M 48.99 M 26.08 M
Total Liabilities 34.90 M 11.30 M 4.04 M 2.75 M 3.86 M
Shareholders' Equity 15.35 M 6.72 M 49.91 M 46.24 M 22.22 M
Total Debt 1.13 M — 600,000.0 0.0 538,000.0
Cash & Equivalents 45.09 M 30.32 M 50.50 M 42.63 M —
Current Assets 50.04 M 36.61 M 53.95 M 48.99 M 26.07 M
Current Liabilities 7.78 M 11.30 M 4.04 M 2.75 M 3.86 M